by The global patient engagement solutions market size was valued at USD 15.6 billion in 2020, and is predicted to be worth around USD 70.2 billion by 2030, registering a CAGR of 17.3% during the forecast period 2022 to 2030.
Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/39139
Table of Contents
Patient Engagement Solutions Market Growth Factors
The key factors fueling the market growth include rising digitalization across healthcare, increasing prevalence of chronic conditions, and technological advancements. The COVID-19 pandemic boosted digitalization across healthcare. This, in turn, has fueled the awareness and adoption of patient engagement solutions, thus propelling the market growth.
Growing technological developments, adoption of EHR and mhealth solutions, the prevalence of chronic diseases, supportive initiatives by key market stakeholders, and consumerism in healthcare are some of the key drivers of this market. As per a 2021 survey by NextGen Healthcare,83% of ambulatory healthcare survey respondents believed that patient engagement solutions played a key role in organizational financial success and patient outcomes. The survey also indicated that the COVID-19 pandemic fueled the market growth.
The COVID-19 pandemic has made unprecedented consequences on daily lives in addition to the worldwide economy. A significant burden is formed on healthcare systems across the globe. Providers, payers, and life science companies began looking for solutions to increase engagement with patients in various settings such as remote home monitoring, virtual consultations, and clinical trials.
Report Coverage
| Report Scope | Details |
| Market Size | US$ 70.2 billion by 2030 |
| Growth Rate | CAGR of 17.3% From 2022 to 2030 |
| Largest Market | North America |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | Delivery Type, Component, Functionality, Therapeutic Area, Application, End user |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Companies Mentioned | Cerner Corporation (Oracle); NextGen Healthcare, Inc.; Epic Systems Corporation; Allscripts Healthcare, LLC; McKesson Corporation; ResMed; Koninklijke Philips N.V.; Klara Technologies, Inc.; CPSI; Experian Information Solutions, Inc.; athenahealth, Inc.; Solutionreach, Inc.; IBM; MEDHOST; Nuance Communications, Inc. |
By Delivery Type Analysis
The web and cloud-based segment dominated the market in 2021 with a revenue share of over 75.0%. The segment is also anticipated to expand at the fastest rate over the forecast period.
The platform is intended to aid providers to advance patient engagement and association among health teams with features such as telehealth and data analytics. On-premise services provide patient data security, easy retrieval, and ease of access.
By Component Analysis
The software and hardware segment accounted for the largest share of over 60.0% in 2021 and is expected to expand at the fastest CAGR over the forecast period. Patient engagement software and hardware form the core offering of the solution.
The services segment is one of the crucial parts of the effective operation of patient engagement solutions. It helps in leveraging and optimizing patient engagement solutions as per the customer needs and to maximize patient health outcomes.
By Functionality Analysis
The communication segment accounted for the largest revenue share of over 35.0% in 2021 as it forms the core offering of any patient engagement solution. This large share is attributed to a surge in demand and adoption of telehealth, mhealth, and other virtual communication solutions via audio, video, and text.
The health tracking and insights segment is projected to grow at the fastest rate of 18.8% over the forecast period. This is owing to the increasing integration of data analytics, AI, and machine learning to present actionable insights to patients and their care providers.
By Therapeutic Area Analysis
Chronic disease management dominated the market in 2021 with a revenue share of over 40.0%. The rising geriatric population in key markets, the prevalence of chronic diseases, and the adoption of digital technologies catalyzed by the COVID-19 pandemic have contributed to the large share of the segment.
The health and wellness segment is anticipated to expand at the fastest rate of 17.7% over the forecast period. This is owing to the initiatives by key companies, the expansion of product offerings to cover mental health, weight management, and pregnancy, and increasing research activities.
By Application Analysis
The outpatient health management segment dominated the market and held a revenue share of over 35.0% in 2021. The others application segment, which includes R&D and preventive care, is anticipated to expand at the fastest rate of 17.7% over the forecast period.
Patient engagement solutions also help the patients to connect with their healthcare providers from remote locations, thereby enabling the streamlined flow of information, patient feedback, and other health-related data.
By End-user Analysis
Providers held the largest revenue share of over 45.0% in 2021. Providers serve the largest volume of patients and are also the primary line of treatment for consultation from general to specialist health concerns. These end users are thus the largest adopters of patient engagement solutions.
The payers end-user segment is estimated to expand at the fastest rate of 17.6% over the forecast period. The growth of the payers segment can be attributed to the increasing adoption of patient and customer engagement solutions that promote widespread coverage and enable value-based care delivery.
By Regional Analysis
North America held the largest revenue share of over 35.0% in 2021 due to the presence of key players, increasing adoption of mhealth and EHR, and growing investment in patient engagement software by the major companies.
The Asia Pacific market is expected to register a lucrative growth rate of 18.8% during the estimated period. The growing penetration of the internet and smartphone users, a large patient population, improving healthcare infrastructure and care quality, and the presence of local players are some of the key factors that are anticipated to offer lucrative growth opportunities to the market over the forecast period.
Read also @ MHealth Market to Reach US$ 126.6 Bn by 2030
Major Key Players Covered in The Patient Engagement Solutions Market Report include
- Cerner Corporation (Oracle)
- NextGen Healthcare, Inc.
- Epic Systems Corporation
- Allscripts Healthcare, LLC
- McKesson Corporation
- ResMed
- Koninklijke Philips N.V.
- Klara Technologies, Inc.
- CPSI
- Experian Information Solutions, Inc.
- athenahealth, Inc.
- Solutionreach, Inc.
- IBM
- MEDHOST
- Nuance Communications, Inc.
Patient Engagement Solutions Market Segmentation
- By Delivery Type
- Web & Cloud-based
- On-premise
- By Component
- Software & Hardware
- Standalone
- Integrated
- Services
- Consulting
- Implementation & Training
- Support & Maintenance
- Others
- Software & Hardware
- By Functionality
- Communication
- Health Tracking & Insights
- Billing & Payments
- Administrative
- Patient Education
- Others
- By Therapeutic Area
- Health & Wellness
- Chronic Disease Management
- Others
- By Application
- Population Health Management
- Outpatient Health Management
- In-patient Health Management
- Others
- End-user
- Payers
- Providers
- Others
- Regional Outlook (Revenue, USD Million, 2017 – 2030)
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Netherlands
- Sweden
- Russia
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- Latin America
- Brazil
- Mexico
- Argentina
- MEA
- South Africa
- Saudi Arabia
- Israel
- UAE
- North America
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Patient Engagement Solutions Market, By Delivery Type
7.1. Patient Engagement Solutions Market, by Delivery Type, 2021-2030
7.1.1. Web & Cloud-based
7.1.1.1. Market Revenue and Forecast (2019-2030)
7.1.2. On-premise
7.1.2.1. Market Revenue and Forecast (2019-2030)
Chapter 8. Global Patient Engagement Solutions Market, By Application
8.1. Patient Engagement Solutions Market, by Application, 2021-2030
8.1.1. Software & Hardware
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Services
8.1.2.1. Market Revenue and Forecast (2019-2030)
Chapter 9. Global Patient Engagement Solutions Market, By Functionality
9.1. Patient Engagement Solutions Market, by Functionality, 2021-2030
9.1.1. Communication
9.1.1.1. Market Revenue and Forecast (2019-2030)
9.1.2. Health Tracking & Insights
9.1.2.1. Market Revenue and Forecast (2019-2030)
9.1.3. Billing & Payments
9.1.3.1. Market Revenue and Forecast (2019-2030)
9.1.4. Administrative
9.1.4.1. Market Revenue and Forecast (2019-2030)
9.1.5. Patient Education
9.1.5.1. Market Revenue and Forecast (2019-2030)
Chapter 10. Global Patient Engagement Solutions Market, By Therapeutic Area
10.1. Patient Engagement Solutions Market, by Therapeutic Area, 2021-2030
10.1.1. Health & Wellness
10.1.1.1. Market Revenue and Forecast (2019-2030)
10.1.2. Chronic Disease Management
10.1.2.1. Market Revenue and Forecast (2019-2030)
Chapter 11. Global Patient Engagement Solutions Market, By Application
11.1. Patient Engagement Solutions Market, by Application, 2021-2030
11.1.1. Population Health Management
11.1.1.1. Market Revenue and Forecast (2019-2030)
11.1.2. Outpatient Health Management
11.1.2.1. Market Revenue and Forecast (2019-2030)
11.1.3. In-patient Health Management
11.1.3.1. Market Revenue and Forecast (2019-2030)
Chapter 12. Global Patient Engagement Solutions Market, By End-user
12.1. Patient Engagement Solutions Market, by End-user, 2021-2030
12.1.1. Payers
12.1.1.1. Market Revenue and Forecast (2019-2030)
12.1.2. Providers
12.1.2.1. Market Revenue and Forecast (2019-2030)
Chapter 13. Global Patient Engagement Solutions Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.1.2. Market Revenue and Forecast, by Application (2019-2030)
13.1.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.1.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.1.5. Market Revenue and Forecast, by Application (2019-2030)
13.1.6. Market Revenue and Forecast, by End-user (2019-2030)
13.1.7. U.S.
13.1.7.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.1.7.2. Market Revenue and Forecast, by Application (2019-2030)
13.1.7.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.1.7.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.1.7.5. Market Revenue and Forecast, by Application (2019-2030)
13.1.7.6. Market Revenue and Forecast, by End-user (2019-2030)
13.1.8. Rest of North America
13.1.8.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.1.8.2. Market Revenue and Forecast, by Application (2019-2030)
13.1.8.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.1.8.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.1.8.5. Market Revenue and Forecast, by Application (2019-2030)
13.1.8.6. Market Revenue and Forecast, by End-user (2019-2030)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.2.2. Market Revenue and Forecast, by Application (2019-2030)
13.2.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.2.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.2.5. Market Revenue and Forecast, by Application (2019-2030)
13.2.6. Market Revenue and Forecast, by End-user (2019-2030)
13.2.7. UK
13.2.7.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.2.7.2. Market Revenue and Forecast, by Application (2019-2030)
13.2.7.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.2.7.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.2.7.5. Market Revenue and Forecast, by Application (2019-2030)
13.2.7.6. Market Revenue and Forecast, by End-user (2019-2030)
13.2.8. Germany
13.2.8.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.2.8.2. Market Revenue and Forecast, by Application (2019-2030)
13.2.8.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.2.8.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.2.8.5. Market Revenue and Forecast, by Application (2019-2030)
13.2.8.6. Market Revenue and Forecast, by End-user (2019-2030)
13.2.9. France
13.2.9.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.2.9.2. Market Revenue and Forecast, by Application (2019-2030)
13.2.9.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.2.9.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.2.9.5. Market Revenue and Forecast, by Application (2019-2030)
13.2.9.6. Market Revenue and Forecast, by End-user (2019-2030)
13.2.10. Rest of Europe
13.2.10.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.2.10.2. Market Revenue and Forecast, by Application (2019-2030)
13.2.10.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.2.10.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.2.10.5. Market Revenue and Forecast, by Application (2019-2030)
13.2.10.6. Market Revenue and Forecast, by End-user (2019-2030)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.3.2. Market Revenue and Forecast, by Application (2019-2030)
13.3.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.3.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.3.5. Market Revenue and Forecast, by Application (2019-2030)
13.3.6. Market Revenue and Forecast, by End-user (2019-2030)
13.3.7. India
13.3.7.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.3.7.2. Market Revenue and Forecast, by Application (2019-2030)
13.3.7.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.3.7.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.3.7.5. Market Revenue and Forecast, by Application (2019-2030)
13.3.7.6. Market Revenue and Forecast, by End-user (2019-2030)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.3.8.2. Market Revenue and Forecast, by Application (2019-2030)
13.3.8.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.3.8.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.3.8.5. Market Revenue and Forecast, by Application (2019-2030)
13.3.8.6. Market Revenue and Forecast, by End-user (2019-2030)
13.3.9. Japan
13.3.9.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.3.9.2. Market Revenue and Forecast, by Application (2019-2030)
13.3.9.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.3.9.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.3.9.5. Market Revenue and Forecast, by Application (2019-2030)
13.3.9.6. Market Revenue and Forecast, by End-user (2019-2030)
13.3.10. Rest of APAC
13.3.10.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.3.10.2. Market Revenue and Forecast, by Application (2019-2030)
13.3.10.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.3.10.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.3.10.5. Market Revenue and Forecast, by Application (2019-2030)
13.3.10.6. Market Revenue and Forecast, by End-user (2019-2030)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.4.2. Market Revenue and Forecast, by Application (2019-2030)
13.4.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.4.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.4.5. Market Revenue and Forecast, by Application (2019-2030)
13.4.6. Market Revenue and Forecast, by End-user (2019-2030)
13.4.7. GCC
13.4.7.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.4.7.2. Market Revenue and Forecast, by Application (2019-2030)
13.4.7.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.4.7.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.4.7.5. Market Revenue and Forecast, by Application (2019-2030)
13.4.7.6. Market Revenue and Forecast, by End-user (2019-2030)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.4.8.2. Market Revenue and Forecast, by Application (2019-2030)
13.4.8.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.4.8.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.4.8.5. Market Revenue and Forecast, by Application (2019-2030)
13.4.8.6. Market Revenue and Forecast, by End-user (2019-2030)
13.4.9. South Africa
13.4.9.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.4.9.2. Market Revenue and Forecast, by Application (2019-2030)
13.4.9.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.4.9.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.4.9.5. Market Revenue and Forecast, by Application (2019-2030)
13.4.9.6. Market Revenue and Forecast, by End-user (2019-2030)
13.4.10. Rest of MEA
13.4.10.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.4.10.2. Market Revenue and Forecast, by Application (2019-2030)
13.4.10.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.4.10.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.4.10.5. Market Revenue and Forecast, by Application (2019-2030)
13.4.10.6. Market Revenue and Forecast, by End-user (2019-2030)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.5.2. Market Revenue and Forecast, by Application (2019-2030)
13.5.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.5.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.5.5. Market Revenue and Forecast, by Application (2019-2030)
13.5.6. Market Revenue and Forecast, by End-user (2019-2030)
13.5.7. Brazil
13.5.7.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.5.7.2. Market Revenue and Forecast, by Application (2019-2030)
13.5.7.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.5.7.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.5.7.5. Market Revenue and Forecast, by Application (2019-2030)
13.5.7.6. Market Revenue and Forecast, by End-user (2019-2030)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Delivery Type (2019-2030)
13.5.8.2. Market Revenue and Forecast, by Application (2019-2030)
13.5.8.3. Market Revenue and Forecast, by Functionality (2019-2030)
13.5.8.4. Market Revenue and Forecast, by Therapeutic Area (2019-2030)
13.5.8.5. Market Revenue and Forecast, by Application (2019-2030)
13.5.8.6. Market Revenue and Forecast, by End-user (2019-2030)
Chapter 14. Company Profiles
14.1. Cerner Corporation (Oracle)
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. NextGen Healthcare, Inc.
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Epic Systems Corporation
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Allscripts Healthcare, LLC
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. McKesson Corporation
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. ResMed
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Koninklijke Philips N.V.
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Klara Technologies, Inc.
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. CPSI
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Experian Information Solutions, Inc.
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms
Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/39139
Contact Us:
Vision Research Reports
Call: +1 9197 992 333
